避孕药市场:现状分析与预测(2022-2028年)
市场调查报告书
商品编码
1290872

避孕药市场:现状分析与预测(2022-2028年)

Contraceptive Pills Market: Current Analysis and Forecast (2022-2028)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 154 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

由于人口增长、计划生育需求增加以及避孕意识提高,避孕药市场预计将以 6% 左右的稳定速度增长。

为了更好地了解避孕药行业的市场采用情况,将市场细分为北美(美国、加拿大、北美其他地区)、欧洲(德国、英国、法国、西班牙、意大利、欧洲其他地区)、亚洲太平洋地区(中国、日本)、印度、亚太地区其他地区)以及世界其他地区。预计北美在预测期内将以显着的复合年增长率增长。这主要是由于该地区 15-44 岁女性人口的增加以及意识的提高。此外,由于仿製药和低成本设备的推出,青少年对避孕药具的需求正在增加。例如,据 Mayne Pharma 称,2021 年 4 月,NEXSTELLIS 获得美国食品和药物管理局的批准。它是第一个也是唯一一个含有 E4 的避孕药,E4 是一种从植物中合成的天然雌激素,具有独特的作用机制。

目录

第1章 市场简介

  • 市场定义
  • 主要目的
  • 相关利益者
  • 限制事项

第2章 调查手法或前提

  • 调查流程
  • 调查手法
  • 受访者简介

第3章 市场概要

第4章 摘要整理

第5章 COVID-19对避孕药市场带来的影响

第6章 避孕药的市场收益,2020-2028年

第7章 市场洞察:各类型

  • 组合避孕药
  • 孕激素丸

第8章 市场洞察:各流通管道

  • 医院药局
  • 零售药局
  • 诊所
  • 线上管道
  • 公共频道和NGO
  • 其他

第9章 市场洞察:各地区

  • 北美
    • 美国
    • 加拿大
    • 其他北美地区
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 全球其他地区

第10章 避孕药市场动态

  • 推动市场要素
  • 市场课题
  • 影响分析

第11章 避孕药市场机会

第12章 避孕药市场趋势

第13章 需求面和供给面的分析

  • 需求面分析
  • 供给面分析

第14章 价值链分析

第15章 价格分析

第16章 策略性洞察能力

第17章 竞争模式

  • 竞争情形
    • 波特的五力分析

第18章 企业简介

  • Pfizer Inc.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Bayer AG
  • Janssen Global Services, LLC
  • HLL Lifecare Limited
  • Mylan N.V.
  • Piramal Enterprises Ltd.
  • Amneal Pharmaceuticals LLC

第19章 免责声明

简介目录
Product Code: UMHE211787

Contraceptive pills, also known as birth control pills, are medications taken orally by women to prevent pregnancy. These pills contain hormones (either a combination of estrogen and progestin or progestin alone) that work to prevent ovulation, the release of an egg from the ovaries. The contraceptive pills market has witnessed steady growth over the past few years due to various factors such as increasing awareness about contraception, the availability of different types of pills, and the rise in sexually active women. The market is driven by factors such as the need for effective family planning, government initiatives to promote contraception, and a rise in the prevalence of sexually transmitted infections (STIs). For instance, as per WHO, around 374 million new cases with 1 of 4 STIs were diagnosed in 2020.

The contraceptive pills market is expected to grow at a steady rate of around 6% owing to the increasing population, the growing demand for family planning, and rising awareness about contraception. For instance, in 2021, Healthy Native Youth announced a sexual health program for American Indian and Alaska Native (AI/AN) youth. Additionally, the development of new formulations, such as extended-cycle pills, low-dose pills, and progestin-only pills, has expanded the market further.

Based on type, the market is segmented into combines contraceptive pills and progestin pills. As per our market study, the combines contraceptive pills category is expected to dominate the contraceptive pills market during the forecast period owing to its high effectiveness rate and convenience for women. Combination pills contain a combination of synthetic estrogen and progestin hormones, which work together to prevent ovulation, thicken cervical mucus to block sperm from reaching the egg, and thin the lining of the uterus to prevent the implantation of a fertilized egg.

On the basis of distribution channel, the market is categorized into hospital pharmacy, retail pharmacy, clinics, online channel, public channel & NGOS, and others. Among these, the retail pharmacy category held the highest share of this market in 2021. This is mainly due to the rising awareness about various forms of contraception and increasing sales of OTC contraceptives, etc. Additionally, growing demand for the improved online distribution channel by collaborating with local sellers will further drive the growth of the market during the forecast period.

For a better understanding of the market adoption of the contraceptive pills industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the increasing women population within the age group of 15-44 years, and growing awareness in the region. Moreover, the launch of generic and low-cost drugs and devices has also led to an increase in the demand for contraceptives by teenagers. For instance, In April 2021, as per Mayne Pharma, the Food and Drug Administration approved NEXSTELLIS. That is the first and only contraceptive drug that contains E4, a naturally occurring estrogen that is now synthesized from a plant source and has a unique mode of action.

Some of the major players operating in the market include: Pfizer Inc.; Merck & Co., Inc.; Teva Pharmaceutical Industries Ltd.; AbbVie Inc.; Bayer AG; Janssen Global Services, LLC; HLL Lifecare Limited; Mylan N.V.; Piramal Enterprises Ltd.; Amneal Pharmaceuticals LLCincreasing

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Contraceptive Pills Market
  • 2.2. Research Methodology of the Contraceptive Pills Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE CONTRACEPTIVE PILLS MARKET

6 CONTRACEPTIVE PILLS MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Combines Contraceptives Pills
  • 7.2. Progestin Pills

8 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

  • 8.1. Hospital Pharmacy
  • 8.2. Retail Pharmacy
  • 8.3. Clinics
  • 8.4. Online Channel
  • 8.5. Public Channel & NGOs
  • 8.6. Others

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 CONTRACEPTIVE PILLS MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 CONTRACEPTIVE PILLS MARKET OPPORTUNITIES

12 CONTRACEPTIVE PILLS MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

  • 18.1. Pfizer Inc.
  • 18.2. Merck & Co., Inc.
  • 18.3. Teva Pharmaceutical Industries Ltd.
  • 18.4. AbbVie Inc.
  • 18.5. Bayer AG
  • 18.6. Janssen Global Services, LLC
  • 18.7. HLL Lifecare Limited
  • 18.8. Mylan N.V.
  • 18.9. Piramal Enterprises Ltd.
  • 18.10. Amneal Pharmaceuticals LLC

19 DISCLAIMER